Expression of Tumor Necrosis Factor Receptor-1 in Arterial Wall Cells Promotes Atherosclerosis
- 1 May 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 27 (5) , 1087-1094
- https://doi.org/10.1161/01.atv.0000261548.49790.63
Abstract
Objective— Mechanisms by which tumor necrosis factor-α (TNF) contributes to atherosclerosis remain largely obscure. We therefore sought to determine the role of the arterial wall TNF receptor-1 (TNFR1) in atherogenesis. Methods and Results— Carotid artery-to-carotid artery interposition grafting was performed with tnfr1−/− and congenic (C57Bl/6) wild-type (WT) mice as graft donors, and congenic chow-fed apolipoprotein E-deficient mice as recipients. Advanced atherosclerotic graft lesions developed within 8 weeks, and had 2-fold greater area in WT than in tnfr1−/− grafts. While the prevalence of specific atheroma cells was equivalent in WT and tnfr1−/− grafts, the overall abundance of cells was substantially greater in WT grafts. WT grafts demonstrated greater MCP-1, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 expression at both early and late time points, and proliferating cell nuclear antigen expression at early time points. Aortic atherosclerosis was also reduced in 14-month-old apoe−/−/tnfr1−/− mice, as compared with cognate apoe−/− mice. In coculture with activated macrophages, smooth muscle cells expressing the TNFR1 demonstrated enhanced migration and reduced scavenger receptor activity. Conclusions— TNFR1 signaling, just in arterial wall cells, contributes to the pathogenesis of atherosclerosis by enhancing arterial wall chemokine and adhesion molecule expression, as well as by augmenting medial smooth muscle cell proliferation and migration. In carotid arterial grafts implanted into apolipoprotein E-deficient mice, TNF receptor-1 deficiency reduced atherosclerotic lesion size by 2-fold. This reduction in atherosclerosis correlated with reduced arterial wall expression of intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and MCP-1, and reduced medial SMC proliferation. TNFR1 deficiency also reduced SMC migration toward activated macrophages.Keywords
This publication has 20 references indexed in Scilit:
- Free Cholesterol-loaded Macrophages Are an Abundant Source of Tumor Necrosis Factor-α and Interleukin-6Journal of Biological Chemistry, 2005
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- Vein Graft Neointimal Hyperplasia Is Exacerbated by Tumor Necrosis Factor Receptor-1 Signaling in Graft-Intrinsic CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Lesion progression and plaque composition are not altered in older apoE−/− mice lacking tumor necrosis factor-α receptor p55Atherosclerosis, 2004
- LRP: Role in Vascular Wall Integrity and Protection from AtherosclerosisScience, 2003
- Neointimal hyperplasia rapidly reaches steady state in a novel murine vein graft modelJournal of Vascular Surgery, 2002
- NF-κB: pivotal mediator or innocent bystander in atherogenesis?Journal of Clinical Investigation, 2001
- Acute-Phase Proteins and Other Systemic Responses to InflammationNew England Journal of Medicine, 1999
- Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55.The Journal of Experimental Medicine, 1993
- Tumour necrosis factor and lymphotoxin genes map close to H–2D in the mouse major histocompatibility complexNature, 1987